Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
High-density Lipoprotein Cholesterol (HDL-C)
100%
Lipoproteins
88%
Low-density Lipoprotein
68%
Coronary Artery Disease
50%
Cholesterol
47%
Apolipoprotein A-I (ApoA-I)
45%
Lipids
43%
Low-density Lipoprotein Cholesterol (LDL-C)
40%
Statins
39%
Human Plasma
33%
Apolipoprotein B (Apo B)
31%
Apoprotein
25%
Plasma Lipoproteins
23%
Statin Therapy
23%
Cholesterol Levels
22%
Triglycerides
21%
Phospholipids
21%
Plasma Lipids
21%
LDL Cholesterol
20%
Phosphatidylglycerol
19%
Phosphatidylcholine
18%
Hypertriglyceridemia
16%
Hypercholesterolemia
16%
Meta-analysis
16%
Dyslipidemia
15%
Prevention Studies
15%
Apolipoprotein C-III
15%
Lipoprotein Lipase
15%
Metabolism
15%
Primary Prevention
14%
Texas
14%
Apolipoprotein B-100
14%
High Density
14%
Lovastatin
13%
Placebo
13%
Atherosclerosis Prevention
12%
Apolipoprotein A-II
12%
Cholesteryl Ester
12%
Risk Factors
12%
Air Force
12%
Cardiovascular Risk
11%
Free Cholesterol
11%
Cardiovascular Disease
11%
Low-density Lipoprotein Cholesterol Level
11%
Apolipoprotein E
11%
Clinical Trials
11%
Fluvastatin
10%
Plasma Cholesterol
10%
ApoB100
10%
Randomized Trial
10%
Biochemistry, Genetics and Molecular Biology
Apolipoprotein
71%
Blood Plasma
68%
Lipid
66%
High-Density Lipoprotein
53%
Lipoprotein
49%
Low-Density Lipoprotein
47%
Phospholipid
26%
Apolipoprotein B
26%
Triglyceride
23%
Very Low-Density Lipoprotein
23%
Lecithin
21%
HDL-Cholesterol
21%
Blood Lipid
18%
Lipoprotein Blood Level
17%
Statin
16%
Metabolic Pathway
16%
Cholesterol Blood Level
13%
Coronary Artery Disease
12%
Dimyristoylphosphatidylcholine
12%
Protein-Lipid Interaction
12%
Apolipoprotein E
11%
Diacylglycerol Lipase
11%
LDL Receptor
10%
Macrophage
10%
Apolipoprotein C2
10%
Amino Acid
9%
Peptide Sequence
9%
Cholesteryl Ester
9%
Lecithin-Cholesterol Acyltransferase
9%
Messenger RNA
9%
Enzyme
9%
Hypercholesterolemia
8%
Blood Level
8%
Oxidoreductase
8%
Hypertriglyceridemia
8%
Fibroblast
7%
Ultracentrifugation
7%
Leporidae
6%
Triacylglycerol Blood Level
6%
Normal Human
6%
C-Terminus
6%
Reductase
6%
Reverse Cholesterol Transport
6%
Fluvastatin
6%
Low Density Lipoprotein Cholesterol Level
6%
Peroxisome Proliferator-Activated Receptor
5%
High Density Lipoprotein Cholesterol Level
5%
Conformation
5%
Lipid Level
5%
Dyslipidemia
5%
Pharmacology, Toxicology and Pharmaceutical Science
Low Density Lipoprotein Cholesterol
51%
Lipoprotein
51%
High Density Lipoprotein Cholesterol
34%
High Density Lipoprotein
33%
Statin (Protein)
32%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
32%
Low Density Lipoprotein
32%
Coronary Artery Disease
30%
Atherosclerosis
29%
Coronary Artery Atherosclerosis
28%
Triacylglycerol
24%
Ischemic Heart Disease
22%
Placebo
18%
Apolipoprotein
16%
Cardiovascular Disease
15%
Very Low Density Lipoprotein
15%
Apolipoprotein A
15%
Clinical Trial
14%
Hypercholesterolemia
14%
Phospholipid
13%
Dyslipidemia
13%
Mevinolin
13%
Lipoprotein Lipase
11%
Apoprotein
11%
Apolipoprotein B
10%
Cardiovascular Risk
10%
Hyperlipidemia
10%
Cholesterol Ester
9%
Oxidoreductase
9%
C Reactive Protein
9%
Fluindostatin
9%
Diseases
8%
Apolipoprotein C2
8%
Egg Lecithin
7%
Lipoprotein A
7%
Low Density Lipoprotein Receptor
7%
Receptor
7%
Amino Acid
7%
Rosuvastatin
7%
Pharmacotherapy
7%
Inflammation
6%
Nicotinic Acid
6%
Heart Infarction
6%
Anacetrapib
5%
Simvastatin
5%
Pitavastatin
5%
High Density Lipoprotein 2
5%
Peroxisome Proliferator Activated Receptor
5%
Fibric Acid Derivative
5%
Antilipemic Agent
5%